Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1016/j.expneurol.2024.114865 | DOI Listing |
Publication Analysis
Top Keywords
corrigendum "ezetimibe
4
"ezetimibe npc1l1
4
npc1l1 inhibitor
4
inhibitor attenuates
4
attenuates neuronal
4
neuronal apoptosis
4
apoptosis ampk
4
ampk dependent
4
dependent autophagy
4
autophagy activation
4
Similar Publications
Corrigendum to: Development and assessment of nano drug delivery systems for combined delivery of rosuvastatin and ezetimibe.
Korean J Physiol Pharmacol
July 2024
Department of Pharmaceutics, Faculty of Pharmacy, Badr University in Cairo, Cairo 11829, Egypt.
Corrigendum to "Ezetimibe, a NPC1L1 inhibitor, attenuates neuronal apoptosis through AMPK dependent autophagy activation after MCAO in rats" [Experimental Neurology, 2018 Sep:307:12-23.].
Exp Neurol
September 2024
Department of Anesthesiology and Basic Sciences, Loma Linda University, School of Medicine, Loma Linda, CA, USA. Electronic address:
Corrigendum to "Monascus purpureus for statin and ezetimibe intolerant heterozygous familial hypercholesterolaemia patients: A clinical study" [Atherosclerosis (Supplements) 30C (2017) 86-91].
Atheroscler Suppl
November 2017
Department of Internal Medicine and Medical Specialties, University of Rome 'Sapienza', Umberto I Hospital, Rome, Italy.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!